Retraction
KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p
Paper Information
Record ID:
32062
Journal:
Publication Date:
April 14, 2020
Retraction Date:
September 01, 2021
(4.2 years years ago)
Subjects:
Institutions:
- Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Department of Bone and Soft Tissue, Zhengzhou Central Affiliated Hospital to Zhengzhou University, Zhengzhou, China
- Department of Bone and Soft Tissue, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
- Key Laboratory of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/15384101.2021.1971878Citations (21)
21
Total Citations12
Post-Retraction(57.1%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
3
After 2+ years
1310
Days since retraction (latest)
Regulation of Skeletogenic Pathways by m6A RNA Modification: A Comprehensive Review
Ehsan Pashay Ahi
Calcified Tissue International
Open Access
Published: Apr 2025
1310 days after retraction
The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer
Bo Ma, Lei Xiu, liliqiang Ding
FASEB BioAdvances
Open Access
Published: Mar 2024
5 citations
5 citations
926 days after retraction
<scp>KIAA1429</scp>/<scp>VIRMA</scp> promotes breast cancer progression by <scp>m<sup>6</sup>A</scp>‐dependent cytosolic <scp>HAS2</scp> stabilization
Na Li, Zhouting Zhu, Yufei Deng et al. (7 authors)
EMBO Reports
Open Access
Published: Sep 2023
12 citations
12 citations
743 days after retraction
Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer
Ziying Zhang, Peng Chen, Jing‐Ping Yun
Frontiers in Genetics
Open Access
Published: Apr 2023
3 citations
3 citations
588 days after retraction
Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients
Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jílková et al. (4 authors)
Livers
Open Access
Published: Feb 2023
4 citations
4 citations
537 days after retraction
Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma
Lei Guo, Qilin Huai, Bolun Zhou et al. (5 authors)
Cancer Innovation
Open Access
Published: Dec 2022
3 citations
3 citations
456 days after retraction
KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
Zhao-chen Liu, Lu-Hao Li, Ding-Yang Li et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Nov 2022
8 citations
8 citations
450 days after retraction
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
Xiaoyu Zhang, Meng jiao Li, Lei Xia et al. (4 authors)
PeerJ
Open Access
Published: Nov 2022
28 citations
28 citations
435 days after retraction
The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
Yanjiao Wu, Zhiyun Wang, Jianlin Shen et al. (7 authors)
Human Genomics
Open Access
Published: Apr 2022
18 citations
18 citations
229 days after retraction
MicroRNA-143 expression inhibits the growth and the invasion of osteosarcoma
Pei Zhang, Jiale Zhang, Huahong Quan et al. (5 authors)
Journal of Orthopaedic Surgery and Research
Open Access
Published: Apr 2022
10 citations
10 citations
224 days after retraction
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets
Jinxin Liu, Guanning Shang
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2022
43 citations
43 citations
168 days after retraction
Advances in the research of osteosarcoma stem cells and its related genes
Weifei Zhang, Liangchen Wei, Jian Weng et al. (7 authors)
Cell Biology International
Published: Dec 2021
8 citations
8 citations
113 days after retraction
SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer
Xu Zhang, Xinyuan Dai, Jiayi Qian et al. (11 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Aug 2021
54 citations
54 citations
13 days before retraction
The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Xinwei Xu, J. Huang, Dickson Kofi Wiredu Ocansey et al. (9 authors)
Journal of Inflammation Research
Open Access
Published: Jul 2021
37 citations
37 citations
62 days before retraction
N6-methyladenosine (m6A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
Tang Jun, Tianci Han, Wei Tong et al. (5 authors)
Cell Death Discovery
Open Access
Published: May 2021
24 citations
24 citations
107 days before retraction
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
Wei Guo, Fengwei Tan, Qilin Huai et al. (11 authors)
Frontiers in Immunology
Open Access
Published: May 2021
75 citations
75 citations
112 days before retraction
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)
Wei Zhu, Jingzi Wang, Ji‐Fu Wei et al. (4 authors)
Cancer Cell International
Open Access
Published: Mar 2021
57 citations
57 citations
168 days before retraction
Identification of potential micro-messenger RNAs (miRNA–mRNA) interaction network of osteosarcoma
Keteng Xu, Pei Zhang, Jiale Zhang et al. (6 authors)
Bioengineered
Open Access
Published: Jan 2021
15 citations
15 citations
243 days before retraction
Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis
Xi Sun, Yi Cai, Xiheng Hu et al. (7 authors)
Translational Cancer Research
Open Access
Published: Nov 2020
13 citations
13 citations
304 days before retraction
The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
Paweł Robak, Izabela Dróźdż, Dariusz Jarych et al. (12 authors)
Cancers
Open Access
Published: Sep 2020
29 citations
29 citations
357 days before retraction
Expression patterns and prognostic value of m6A-related genes in colorectal cancer.
Xin Liu, Liwen Liu, Zihui Dong et al. (9 authors)
PubMed
Published: Jan 2019
124 citations
124 citations
974 days before retraction
Quick Stats
Total Citations:
21
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025